Mehdi Hamadani

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Aniko Szabo

UNITED STATES

View details

sairah ahmed

associate professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Carmelo Carlo‐Stella

ITALY

View details

LaQuisa Hill

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Larry Anderson

Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

Martin Hutchings

Professor

University of Copenhagen

DENMARK

View details

Cole Sterling

Assistant Professor

Johns Hopkins University

UNITED STATES

View details

Nausheen Ahmed

Assistant Professor

University of Kansas Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mehdi Hamadani

Research Interests

Explore related searches

Contact this professor

Articles (11)

Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL‐102): A phase 1 study

Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma

Salvage polatuzumab and allogeneic transplant rescue patients with B-cell lymphoma failing CAR T-cell therapy

Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiotepa/carmustine conditioning

Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas

ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Diffuse Large B-cell Lymphoma after Failure of Chimeric Antigen Receptor T Cell Therapy (CAR-T) Therapy

Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

THE ANTIBODY-DRUG CONJUGATE LONCASTUXIMAB TESIRINE FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA

Characteristics and Clinical Outcomes of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Who Received At Least 3 Lines of Therapies

Promise and pitfalls of allogeneic chimeric antigen receptor therapy in plasma cell and lymphoid malignancies

Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics

Collaborators (8)

Aniko Szabo

sairah ahmed

Carmelo Carlo‐Stella

LaQuisa Hill

Larry Anderson

Martin Hutchings

Cole Sterling

Nausheen Ahmed

Make your next move.